{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:39:44Z","timestamp":1786736384555,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Gastroenterol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/sjg.sjg_80_19","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T03:50:38Z","timestamp":1569469838000},"page":"286","source":"Crossref","is-referenced-by-count":9,"title":["Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients"],"prefix":"10.4103","volume":"25","author":[{"given":"FaisalM","family":"Sanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FatimaA","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaryamS","family":"Bajaifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammedA","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduljaleel","family":"Alalwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FaraazA","family":"Sanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Albeladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdulrahmanA","family":"Aljumah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-3767.257329-1","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1002\/hep.20970","article-title":"Therapy of hepatitis B \u2014 Viral suppression or eradication?","author":"Perrillo","year":"2006","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.257329-2","first-page":"383","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study","author":"Polaris","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.257329-3","doi-asserted-by":"crossref","unstructured":"Sanai FM, Alghamdi H, Alswat KA, Babatin MA, Ismail MH, Alhamoudi WK, et al. Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia. Saudi J Gastroenterol 2019. doi: 10.4103\/sjg.SJG_447_18. [Ahead of print].","DOI":"10.4103\/sjg.SJG_447_18"},{"key":"key-10.4103\/1319-3767.257329-4","doi-asserted-by":"crossref","unstructured":"Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, et al. Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions. Saudi J Gastroenterol 2019. doi: 10.4103\/sjg.SJG_421_18. [Ahead of print].","DOI":"10.4103\/sjg.SJG_421_18"},{"key":"key-10.4103\/1319-3767.257329-5","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/hep.22976","article-title":"Evaluation of the patient with hepatitis B","author":"Rotman","year":"2009","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.257329-6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.257329-7","first-page":"5","article-title":"SASLT practice guidelines for the management of hepatitis B virus","author":"Abaalkhail","year":"2014","journal-title":"Saudi J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/1319-3767","issn-type":"print"},{"key":"key-10.4103\/1319-3767.257329-8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.257329-9","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182a9a2e1","article-title":"Predictors of significant fibrosis in chronic hepatitis B patients with low viremia","author":"Abdo","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"key-10.4103\/1319-3767.257329-10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u201cNew\u201d antigen in leukemia sera","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"key":"key-10.4103\/1319-3767.257329-11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jhep.2010.01.014","article-title":"Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective","author":"Jaroszewicz","year":"2010","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.257329-12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2011.06.006","article-title":"Hepatitis B surface antigen quantification: Why and how to use it in 2011 \u2013 A core group report","author":"Chan","year":"2011","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.257329-13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.257329-14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.23803","article-title":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B","author":"Chan","year":"2010","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.257329-15","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","article-title":"Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.257329-16","first-page":"252","article-title":"Correlation between hepatitis B surface antigen titers and HBV DNA levels","author":"Alghamdi","year":"2013","journal-title":"Saudi J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/1319-3767","issn-type":"print"},{"key":"key-10.4103\/1319-3767.257329-17","doi-asserted-by":"crossref","first-page":"e43087","DOI":"10.1371\/journal.pone.0043087","article-title":"High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B","author":"Seto","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/1319-3767.257329-18","doi-asserted-by":"crossref","unstructured":"Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, et al. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis. Clin Gastroenterol Hepatol 2013;11:1493-9.e2.","DOI":"10.1016\/j.cgh.2013.05.038"},{"key":"key-10.4103\/1319-3767.257329-19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jvh.12756","article-title":"Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?","author":"Chakrabarty","year":"2018","journal-title":"J Viral Hepat"},{"key":"key-10.4103\/1319-3767.257329-20","doi-asserted-by":"crossref","first-page":"86463","DOI":"10.18632\/oncotarget.21210","article-title":"Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"key-10.4103\/1319-3767.257329-21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/1319-3767.182454","article-title":"Are serum quantitative hepatitis B surface antigen levels, liver histopathology and viral loads related in chronic hepatitis B-infected patients?","author":"Balkan","year":"2016","journal-title":"Saudi J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/1319-3767","issn-type":"print"},{"key":"key-10.4103\/1319-3767.257329-22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","author":"Chen","year":"2006","journal-title":"JAMA"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:41:05Z","timestamp":1786732865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.SJG_80_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["257329"],"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_80_19","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}